Oculis Holding AG (OCS) Free Cash Flow (2022 - 2026)

Oculis Holding AG's (OCS) quarterly Free Cash Flow came in at -$19.6 million in Q1 2026, up 7.12% year-on-year from -$18.3 million in Q1 2025, and up 5.99% quarter-over-quarter from -$20.8 million in Q4 2025.

Oculis Holding AG (OCS) Free Cash Flow (2022 - 2026) Analysis & Trends

Oculis Holding AG's Free Cash Flow history runs 5 years deep, the most recent figure standing at -$19.6 million for Q1 2026.

  • On a quarterly basis, Free Cash Flow rose 7.12% year-over-year to -$19.6 million in Q1 2026; TTM through Mar 2026 was -$77.7 million, a 28.08% decrease from a year earlier, with the FY2025 full-year figure at -$79.6 million, down 43.84% from the prior year.
  • Free Cash Flow improved to -$19.6 million in Q1 2026 per OCS's latest filing, from -$20.8 million in the prior quarter.
  • Across five years, Free Cash Flow topped out at -$5.2 million in Q4 2022 and bottomed at -$21.1 million in Q1 2025.
  • The 5-year median for Free Cash Flow is -$15.7 million (2024), against an average of -$15.1 million.
  • Across the five-year window, Free Cash Flow tumbled 210.52% in 2023 and rose 24.53% in 2024, its largest moves.
  • Year by year, Free Cash Flow stood at -$5.2 million in 2022, then tumbled by 210.52% to -$16.0 million in 2023, then advanced by 24.53% to -$12.1 million in 2024, then sank by 72.3% to -$20.8 million in 2025, then increased by 5.99% to -$19.6 million in 2026.
  • Per Business Quant, the three latest OCS Free Cash Flow figures stand at -$19.6 million (Q1 2026), -$20.8 million (Q4 2025), and -$16.6 million (Q3 2025).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Free Cash Flow (Qtr)
1 Oculis Holding AG 67,072.09 Bn 67,072.09 Bn - -19.58 Mn
2 Nanobiotix 1,894.61 Bn 1,894.55 Bn - -
3 Akari Therapeutics 1,014.18 Bn 1,014.18 Bn - -2.49 Mn
4 BeOne Medicines 471.64 Bn 466.85 Bn 1.35 Bn 158.09 Mn
5 Vertex Pharmaceuticals 121.72 Bn 114.47 Bn 2.59 Bn 1.29 Bn
6 Regeneron Pharmaceuticals 68.28 Bn 59.52 Bn 3.31 Bn 848.30 Mn
7 Belite Bio 61.40 Bn 61.40 Bn - -
8 Argenx Se 56.94 Bn 56.94 Bn 1.18 Bn -
9 Revolution Medicines 37.37 Bn 37.37 Bn - -354.95 Mn
10 Alnylam Pharmaceuticals 36.08 Bn 33.07 Bn 959.66 Mn 48.67 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 -19.58 Mn
Mar 31, 2026 -19.58 Mn
Dec 31, 2025 -20.82 Mn
Dec 31, 2025 -20.82 Mn
Sep 30, 2025 -16.62 Mn
Sep 30, 2025 -16.62 Mn
Jun 30, 2025 -20.67 Mn
Jun 30, 2025 -20.67 Mn
Mar 31, 2025 -21.08 Mn
Mar 31, 2025 -21.08 Mn
Dec 31, 2024 -12.09 Mn
Dec 31, 2024 -12.09 Mn
Sep 30, 2024 -12.31 Mn
Sep 30, 2024 -12.31 Mn
Jun 30, 2024 -15.19 Mn
Jun 30, 2024 -15.19 Mn
Mar 31, 2024 -15.72 Mn
Mar 31, 2024 -15.72 Mn
Dec 31, 2023 -16.01 Mn
Dec 31, 2023 -16.01 Mn